Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study

Background: Epilepsy is a common symptom of brain tumors and is often pharmacoresistent. Among new antiseizure medications (ASMs) Brivaracetam (BRV) has been approved as adjunctive treatment for focal seizures and it was tested in non-oncological patient populations. This is the first study that ret...

Full description

Bibliographic Details
Main Authors: Marta Maschio, Andrea Maialetti, Cristina Mocellini, Elisabetta Domina, Giada Pauletto, Cinzia Costa, Addolorata Mascia, Michele Romoli, Diana Giannarelli
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.00813/full